To Evaluate The Effect Of Kalingadi Taila Nasya(medicated nasal drop instillation therapy) and Shigru Taila Nasya In The Management Of Apeenasa(chronic rhino sinusitis)

AN OPEN LABEL DOUBLE ARM STUDY ON THE EFFECT OF SHIGRU TAILA NASYA AND KALINGADI TAILA NASYA IN MANAGEMENT OF APEENASA - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033902

Enrollment

Registered

2021-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

Intervention1: shigru taila nasya: nasya treatment with shigru taila 8 drops once a day in the morning for 7 days Control Intervention1: kalingadi taila nasya: nasya treatment with kalingadi taila 8 d

Eligibility

Inclusion criteria

Inclusion criteria: patients diagnosed with apeenasa will be randomly selected for the study patient fit for nasya

Exclusion criteria

Exclusion criteria: patient with history of systemic illness that interfere with the course of study patients requiring surgical interference apeenasa associated with nasal polyp and nasal malignancies congenital anomalies of nasal cavity

Design outcomes

Primary

Measure	Time frame
TO COMPARE THE EFFECT OF KALINGADI TAILA NASYA AND SHIGRU TAILA NASYA IN MANAGEMENT OF APEENASATimepoint: DURATION OF TREATMENT- 7 DAYS FOLLOW UP 1 - 15th DAY FOLLOW UP 2 - 30TH DAY	—

Secondary

Measure	Time frame
nilTimepoint: not applicable	—

Countries

India

Contacts

Public ContactDr Sujathamma K

SKAMCH AND RC

drsujathammaskamc@gmail.com9448848786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026